Arkadios Wealth Advisors increased its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 15.7% during the third quarter, Holdings Channel.com reports. The institutional investor owned 45,880 shares of the company’s stock after purchasing an additional 6,229 shares during the period. Arkadios Wealth Advisors’ holdings in Procter & Gamble were worth $7,946,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in PG. Acorn Creek Capital LLC grew its position in Procter & Gamble by 2.8% in the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after acquiring an additional 59 shares in the last quarter. Patrick M Sweeney & Associates Inc. grew its holdings in shares of Procter & Gamble by 1.1% in the third quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after purchasing an additional 59 shares in the last quarter. Alera Investment Advisors LLC increased its stake in Procter & Gamble by 1.2% during the 1st quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock worth $812,000 after buying an additional 60 shares during the period. Hudson Value Partners LLC lifted its holdings in Procter & Gamble by 4.1% during the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock worth $250,000 after buying an additional 60 shares in the last quarter. Finally, Traveka Wealth LLC boosted its position in Procter & Gamble by 1.7% in the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after buying an additional 60 shares during the period. 65.77% of the stock is owned by institutional investors.
Procter & Gamble Stock Performance
PG traded down $1.40 during trading on Friday, hitting $168.22. 4,877,911 shares of the stock were exchanged, compared to its average volume of 6,669,386. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94. The stock has a fifty day moving average price of $171.93 and a two-hundred day moving average price of $167.55. The firm has a market capitalization of $396.16 billion, a P/E ratio of 29.00, a PEG ratio of 3.67 and a beta of 0.41.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $1.0065 per share. The ex-dividend date is Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.39%. Procter & Gamble’s dividend payout ratio (DPR) is 69.48%.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on the company. TD Cowen began coverage on Procter & Gamble in a research report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price objective on the stock. JPMorgan Chase & Co. increased their price target on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. StockNews.com cut Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Finally, Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a research note on Monday, September 30th. Nine research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $177.00.
Get Our Latest Stock Report on Procter & Gamble
Insider Buying and Selling
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the sale, the insider now directly owns 11,566 shares of the company’s stock, valued at approximately $1,954,538.34. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Susan Street Whaley sold 450 shares of the stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $76,149.00. Following the completion of the transaction, the insider now directly owns 13,072 shares of the company’s stock, valued at $2,212,043.84. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the sale, the insider now owns 11,566 shares of the company’s stock, valued at approximately $1,954,538.34. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 397,986 shares of company stock valued at $67,642,430 over the last quarter. 0.18% of the stock is currently owned by insiders.
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- How to Invest in the Best Canadian Stocks
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Health Care Stocks Explained: Why You Might Want to Invest
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Investing in Travel Stocks Benefits
- MarketBeat Week in Review – 10/21- 10/25
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.